BioSpace News Archive

BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) today announced Q2 2022 sales orders of its flagship VINIA® product reached a record high of USD 947k, representing 99% growth compared to the same quarter of last year and 24% growth compared to Q1 2022.

The global Fish Vaccine market size is estimated to be worth US$ 338.6 million in 2021 and is forecast to a readjusted size of US$ 631.5 million by 2030 with a CAGR of 9.2% during the forecast period 2022-2030.

A recent report provides crucial insights along with application based and forecast information in the Global Endomucin Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Endomucin market.

A recent report provides crucial insights along with application based and forecast information in the Global Basic Infusion Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market.

The global Compounding Pharmacy market size is projected to reach US$ 13970 million by 2030, from US$ 11570 million in 2021, at a CAGR of 2.7% during 2022-2030.

AMRA Medical, a digital health company delivering a new standard in body composition analysis through rapid whole-body magnetic resonance imaging (MRI), today announced that the results of their Fulcrum-sponsored study highlighting the development and use of a whole-body MRI protocol for muscle analysis are now published in Neurology.

The global Essential Tremor Treatment market size is estimated to be worth US$ 158 million in 2021 and is forecast to a readjusted size of US$ 224.7 million by 2030 with a CAGR of 5.1% during the forecast period 2022-2030.

The global Cell Culture Protein Surface Coatings market size is estimated to be worth US$ 164 million in 2021 and is forecast to a readjusted size of US$ 336.8 million by 2030 with a CAGR of 10.7% during the forecast period 2022-2030.

The global Biosimilar Monoclonal Antibodies market size is estimated to be worth US$ 4509.2 million in 2021 and is forecast to a readjusted size of US$ 12960 million by 2030 with a CAGR of 16.0% during the forecast period 2022-2030.

A recent report provides crucial insights along with application based and forecast information in the Global Generic Tofacitinib Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market.